Extend the $35 insulin cap to all Americans with private insurance.

Steven Horsford · Nevada · Democratic

policy impact 4.00 specificity 1.00 extraction confidence 98%

Occurrences

The Affordable Insulin Now Act (H.R. 6255) would extend the $35 insulin cap to all Americans with private insurance.

Horsford says he introduced legislation to extend the $35 insulin cap to privately insured Americans.

Horsford Marks 16 Years of the Affordable Care Act, Warns of Republican Healthcare Crisis Hitting Nevada Families | Congressman Steven Horsford
primary · press_release · model gpt-5.4-mini

Evidence

AP reports that a new bipartisan INSULIN Act was introduced on April 2, 2026 to cap insulin at $35 per month for Americans with private insurance, and notes that a similar 2022 House-passed effort did not clear the Senate.

The policy is still being actively pursued in 2026, which shows the private-insurance cap remains unresolved rather than delivered.

unresolved later_term

Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs
secondary · model gpt-5.4-mini · confidence 90%

The House Clerk shows H.R. 6833, the Affordable Insulin Now Act, passed the House 232-193 on March 31, 2022; Steven Horsford voted Yea.

Horsford took a concrete pro-cap action, but the House passage did not by itself deliver the private-insurance cap.

unresolved same_term A for effort

Roll Call 102 | Bill Number: H. R. 6833
secondary · model gpt-5.4-mini · confidence 99%

Axios reported that Senate Republicans blocked the proposed $35 insulin cap for patients with private insurance from being included in the 2022 reconciliation bill, leaving the private-insurance version out of the package.

The federal attempt to extend the cap to private insurance was blocked before enactment.

never same_term

Insulin price cap for private insurers pulled from reconciliation bill
secondary · model gpt-5.4-mini · confidence 93%

Medicare.gov currently says covered insulin costs no more than $35 for a one-month supply of each Part B- and Part D-covered insulin product, confirming the federal cap exists for Medicare coverage.

The cap was delivered for Medicare beneficiaries, but this page does not extend it to private insurance.

partial later_term

Insulin | Medicare
secondary · model gpt-5.4-mini · confidence 98%

Assessments

never same_term A for effort

Horsford supported the promised policy by voting for the 2022 Affordable Insulin Now Act after the House passed a $35 insulin cap that included private insurance, so he made a meaningful legislative attempt. But the private-insurance cap did not become federal law: Senate action stripped or blocked that provision, and the enacted federal $35 cap applies to Medicare rather than all Americans with private insurance. Continued 2026 efforts to pass a private-insurance cap further indicate the promised outcome remains undelivered.

provider codex_cli · model gpt-5.4 · confidence 95%